Medical task force says more people should be taking HIV prevention drug
The U.S. Preventive Services Task Force issued a recommendation on Tuesday in the pursuit of HIV prevention. Pre-exposure prophylaxis, also known as PrEP, has been proven effective in preventing people from getting HIV if it's taken regularly, and the task force is now suggesting that people who are at risk of being infected should have access to a daily pill to lower their likelihood of contracting the disease. The recommendation letter was published in the Journal of the American Medical Association alongside an editorial by two physicians involved in HIV research.
While the Centers for Disease Control and Prevention has long recommended PrEP as "a powerful HIV prevention tool," less than 10 percent of at-risk individuals currently take it, NPR reports. People at high risk include men who have sex with other men, as well as people who inject drugs — and "black and Latino men who have sex with men" are among the people whose rate of getting PrEP is especially low, despite their risk, details the editorial.
While treatment for HIV has improved vastly since its discovery, little progress has been made in preventing new cases. One factor could be the cost of preventive medicine: PrEP can cost over $20,000 for a year's supply. Lack of awareness could be another — having unprotected sex with a partner who hasn't disclosed their HIV status presents a high risk as well.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Read more about PrEP and the U.S. Preventive Services Task Force's recommendation at NPR.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Shivani is the editorial assistant at TheWeek.com and has previously written for StreetEasy and Mic.com. A graduate of the physics and journalism departments at NYU, Shivani currently lives in Brooklyn and spends free time cooking, watching TV, and taking too many selfies.
-
The best body horror movies of the last half-century
The Week Recommends If 'The Substance' piqued your interest, these other films will likely be your speed
By Theara Coleman, The Week US Published
-
Why are CEOs having second thoughts about Trump?
Today's Big Question Tariff threats and economic warning signs create corporate uncertainty
By Joel Mathis, The Week US Published
-
Why Japanese residents can’t watch their country’s Oscar-nominated #MeToo documentary
THE EXPLAINER Shiori Ito became one of the faces of Japan's #MeToo movement. Her documentary about that experience, 'Black Box Diaries,' is up for an Academy Award, even as it struggles to be screened back home.
By Rafi Schwartz, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published